Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Berberine and Reduced Blood Cholesterol

Research synthesisModerate evidenceSmall effect4 studies · 3 beneficial · 1 neutral · 0 harmful

The evidence indicates that berberine shows small beneficial effects on reducing total cholesterol, with 3 of 4 studies reporting significant reductions. Effects were typically observed at a dose of approximately 500 mg twice daily over a median of 84 days, primarily in clinical populations such as Chinese men with hyperlipidemia. One neutral study in patients with type 2 diabetes found no difference in total cholesterol, suggesting context-dependent efficacy.

  • Effective dose range: 500 mg twice daily (1000 mg/day) to 1200 mg/day
  • Studied populations: Clinical populations including Chinese men with hyperlipidemia and patients with type 2 diabetes

Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). The neutral finding in patients with type 2 diabetes suggests benefits may not generalize to all metabolic conditions.

Generated Jul 15, 2026
Doses used in studies
  • mg/day: 1,000–1,200 (median 1,100, IQR 1,050–1,150) — 2 studies
Time to effect
Median: 2.8 months · IQR 2.8 months–2.8 months · Range 2.8 months–2.8 months — Reported in 2 of 4 studies
Safety in these studies
4 of 4 papers
Back to top